Toronto Dominion Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Toronto Dominion Bank's PFE Position: Q1 2026 in Review
Toronto Dominion Bank reduced its Pfizer (PFE) stake by 47% in Q1 2026, selling an estimated $40.5M and leaving 1,713,006 shares worth $48.1M. The position accounts for 0.07% of the portfolio, ranked #245.
Toronto Dominion Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $419M in Q4 2019. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Toronto Dominion Bank held 1,713,006 shares of Pfizer worth $48.1M as of Q1 2026.
- Toronto Dominion Bank sold 1,521,330 Pfizer shares in Q1 2026, an estimated $40.5M.
- Pfizer made up 0.07% of Toronto Dominion Bank's portfolio in Q1 2026, its #245 holding.
- Toronto Dominion Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Toronto Dominion Bank's Pfizer position peaked at $419M in Q4 2019.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.